Monitoring exposure of hospital personnel handling cytostatic drugs and contaminated materials
- 1 February 1995
- journal article
- research article
- Published by Springer Nature in Internationales Archiv für Arbeitsmedizin
- Vol. 66 (6) , 363-368
- https://doi.org/10.1007/bf00383141
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Mechanisms of inhibitors of mutagenesis and carcinogenesis. Classification and overviewMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1988
- Applicability of the SOS Chromotest to detect urinary mutagenicity caused by smokingMutagenesis, 1988
- Limitations of the salmonella/mammalian microsome assay (AMES test) to determine occupational exposure to cytostatic drugsEuropean Journal of Cancer and Clinical Oncology, 1986
- Isolation of frameshift mutagens from smokers' urine: experiences with three concentration methodsCarcinogenesis: Integrative Cancer Research, 1985
- Mutagenicity testing with TA97 and TA102 of 30 DNA-damaging compounds, negative with other Salmonella strainsMutation Research/Reviews in Genetic Toxicology, 1984
- OCCUPATIONAL EXPOSURE TO CYCLOPHOSPHAMIDEThe Lancet, 1984
- MONITORING EXPOSURE OF NURSING AND PHARMACY PERSONNEL TO CYTOTOXIC DRUGS: URINARY MUTATION ASSAYS AND URINARY PLATINUM AS MARKERS OF ABSORPTIONThe Lancet, 1984
- Detection of occupational exposure to genotoxic agents with a urinary mutagen assayMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1983
- LACK OF MUTAGENIC ACTIVITY IN URINE FROM HOSPITAL PHARMACISTS ADMIXING ANTITUMOUR DRUGSThe Lancet, 1981
- MUTAGENICITY IN URINE OF NURSES HANDLING CYTOSTATIC DRUGSThe Lancet, 1979